Impact of comorbidities in elderly and frail patients and response to biological therapy in psoriasis.

Keywords: biologics; comorbidities; frail patients; PASI; psoriasis EN biologics comorbidities frail patients PASI psoriasis 1162 1164 3 07/14/23 20230701 NES 230701 DATA AVAILABILITY STATEMENT The data that support the findings of this study are available on request from the corresponding author. In this analysis, we clustered patients into two groups: patients who reported at least one comorbidity at the time of the diagnosis (219, 78.21%) and those who denied comorbidities (61, 21.79%). The most represented comorbidities were hypertension (105 patients), type 2 diabetes mellitus (32 patients), dyslipidaemia (26 patients), acute ischemic cardiopathy (25 patients), COPD (13 patients), symptomatic benign prostatic hyperplasia (19 patients), arthrosis (11 patients), HCV (nine patients), asthma (five patients) and other (81 patients). [Extracted from the article]